US 9358285
Granulysin in immunotherapy
granted A61KA61K2039/55516A61K2039/55522
Quick answer
US patent 9358285 (Granulysin in immunotherapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/55516, A61K2039/55522, A61K2039/55527, A61K2239/57